Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-006211

SVP & Chief Accounting Officer sold 75,000 shares at $18.62 ($1,396,500)

  • SVP & Chief Accounting Officer acquired 75,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Thomsen Jillian B. · SVP & Chief Accounting Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-28 Exercise or conversion : show line 1 in the form +37,500 $8.80 $330,000 213,757 D
2021-01-28 Exercise or conversion : show line 2 in the form +37,500 $8.80 $330,000 251,257 D
2021-01-28 Sale : show line 3 in the form −75,000 $18.62 $1,396,500 176,257 D
Open-market sales · 75,000 sh · avg $18.62 · $1,396,500

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-01-28 Exercise or conversion : show line 4 in the form Stock Option −37,500 0 D
2021-01-28 Exercise or conversion : show line 5 in the form Stock Option −37,500 0 D
Loading xslF345X03/doc4.xml…